Targeting matrilysin and its impact on tumor growth in vivo: The potential implications in breast cancer therapy

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 6012-6019

  Jiang, Wen G ^a,c   Davies, Gaynor ^a   Martin, Tracey A ^a   Parr, Christian ^a   Watkins, Gareth ^a   Mason, Malcolm D ^a   Mokbel, Kefah ^b   Mansel, Robert E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b George's Hospital Medical School   (United Kingdom)

^c University Department of Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAMMERHEAD RIBOZYME; MATRILYSIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CANCER THERAPY; CONTROLLED STUDY; DRUG TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RETROVIRUS; TRANSGENE; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 7; MICE; MICE, NUDE; NIH 3T3 CELLS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSFECTION; TRANSGENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 23844431620     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0275     Document Type: Article

References (35)

1. Muller D, Quantin B, Gesnel M-C, et al. The collagenase gene family in humans consists of at least four members. Biochem J 1988;253:187-92.
2. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994;269:2032-40.
3. Wilson CL, Matrisian LM. Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996;28:123-36.
4. Crawford HC, Fingleton BM, Rudolph-Owen LA, et al. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 1999;18:2883-91.
5. Crawford HC, Fingleton B, Gustavson MD, et al. The PEA3 subfamily of Ets transcription factors synergizes with p-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 2001;21:1370-83.
6. Hasegawa S, Koshikawa N, Momiyama N, et al. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int J Cancer 1988;76:812-6.
7. Abdel-Ghany M, Cheng HC, Elble RC, Pauli BU. The breast cancer β(4) integrin and endothelial human CLCA2 mediate lung metastasis. J Biol Chem 2001;276:25438-46.
8. Yu WH, Woessner JF Jr, McNeish JD, Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002;16:307-23.
9. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in HGF/SF induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 2001;7:3289-97.
10. Noe V, Fingleton B, Jacobs K, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001;114:111-8.
11. Rudolph-Owen LA, Cannon P, Matrisian LM. Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Mol Biol Cell 1998;9:421-35.
12. Rudolph-Owen LA, Matrisian LM. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1998;3:177-89.
13. Pacheco MM, Mourao M, Mantovani EB, Nishimoto IN, Brentani MM. Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations. Clin Exp Metastasis 1998;16:577-85.
14. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996;149:273-82.
15. Jiang WG, Watkins G, Lane J, et al. Prognostic value of Rho family and rho-GDIs in breast cancer. Clin Cancer Res 2003;9:6432-40.
16. Jiang WG, Grimshaw D, Leterra J, Abounader R, Lane J, Mansel RE. Suppression of invasiveness and cellular motility of breast cancer cells by a hammerhead ribozyme encoding cMET antisense. Clin Cancer Res 2001;7:2555-62.
17. Jiang WG, Davies G, Fodstad O. Com-1/p8 in oestrogen regulated growth of breast cancer cells, the ER-β connection. Biochem Biophys Res Commun 2005;330:253-62.
18. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003;31:3406-15.
19. Jiang WG, Grimshaw D, Lane J, et al. Retroviral hammerhead transgenes to cMET and HGF/SF inhibited growth of breast tumor, induced by fibroblasts. Clin Cancer Res 2003;9:4274-81.
20. Nazarenko IA, Bhatnagar SK, Hohman RJ. A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res 1997;25:2516-21.
21. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. Differential expression of the CCN family members Cyr61 from CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004;11:781-91.
22. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE, Puntis MCA. Regulation of the expression of E-cadherin on human cancer cells by γ linolenic acid. Cancer Res 1995;55:5043-8.
23. Davies G, Jiang WG, Mason MD. Cell-cell adhesion and signalling intermediates in human prostate cancer. J Urology 2000;163:985-92.
24. King JAC, Ofori-Acquah AF, Stevens T, et al. Prognostic value of ALCAM in human breast cancer. Breast Cancer Res 2004;6:R478-87.
25. Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Res 2002;62:5559-63.
26. Crawford HC, Fingleton B, Gustavson MD, et al. The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 2001;21:1370-83.
27. Miyamoto S, Yano K, Sugimoto S, et al. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res 2004;64:665-71.
28. Rivat C, Le Floch N, Sabbah M, et al. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. FASEB J 2003;17:1721-3.
29. McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003;162:1831-43.
30. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002;111:635-46.
31. Masaki T, Matsuoka H, Sugiyama M, et al. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 2001;84:1317-21.
32. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002;277:36288-95.
33. Patterson BC, Sang QA. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 1997;272:28823-5.
34. Huo N, Ichikawa Y, Kamiyama M, et al. MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 2002;177:95-100.
35. Yu WH, Woessner JF Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 2000;275:4183-91.